You just read:

Elusys Therapeutics Announces Publication Of Data Establishing The Adult Human Dose For Its Inhalational Anthrax Antitoxin, ANTHIM® (obiltoxaximab) Injection

News provided by

Elusys Therapeutics, Inc.

Dec 20, 2016, 13:14 ET